Logo image of IVG.MI

IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis

Europe - BIT:IVG - NL0015000LU4 - Common Stock

18.075 EUR
-0.11 (-0.58%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to IVG. IVG was compared to 103 industry peers in the Machinery industry. IVG has a medium profitability rating, but doesn't score so well on its financial health evaluation. IVG is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year IVG was profitable.
IVG had a positive operating cash flow in the past year.
Of the past 5 years IVG 4 years were profitable.
In the past 5 years IVG always reported a positive cash flow from operatings.
IVG.MI Yearly Net Income VS EBIT VS OCF VS FCFIVG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

With a Return On Assets value of 1.73%, IVG perfoms like the industry average, outperforming 42.72% of the companies in the same industry.
With a decent Return On Equity value of 12.39%, IVG is doing good in the industry, outperforming 73.79% of the companies in the same industry.
IVG's Return On Invested Capital of 4.53% is in line compared to the rest of the industry. IVG outperforms 43.69% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IVG is below the industry average of 8.61%.
The 3 year average ROIC (3.91%) for IVG is below the current ROIC(4.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.73%
ROE 12.39%
ROIC 4.53%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
IVG.MI Yearly ROA, ROE, ROICIVG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 2.17%, IVG is in line with its industry, outperforming 41.75% of the companies in the same industry.
In the last couple of years the Profit Margin of IVG has grown nicely.
IVG has a Operating Margin of 5.00%. This is comparable to the rest of the industry: IVG outperforms 45.63% of its industry peers.
IVG's Operating Margin has improved in the last couple of years.
IVG's Gross Margin of 16.49% is on the low side compared to the rest of the industry. IVG is outperformed by 89.32% of its industry peers.
IVG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5%
PM (TTM) 2.17%
GM 16.49%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
IVG.MI Yearly Profit, Operating, Gross MarginsIVG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

3

2. Health

2.1 Basic Checks

IVG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, IVG has less shares outstanding
Compared to 5 years ago, IVG has more shares outstanding
Compared to 1 year ago, IVG has an improved debt to assets ratio.
IVG.MI Yearly Shares OutstandingIVG.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IVG.MI Yearly Total Debt VS Total AssetsIVG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.76, we must say that IVG is in the distress zone and has some risk of bankruptcy.
IVG has a Altman-Z score of 1.76. This is comparable to the rest of the industry: IVG outperforms 42.72% of its industry peers.
IVG has a debt to FCF ratio of 14.82. This is a negative value and a sign of low solvency as IVG would need 14.82 years to pay back of all of its debts.
The Debt to FCF ratio of IVG (14.82) is worse than 66.99% of its industry peers.
IVG has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.35, IVG is not doing good in the industry: 83.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 14.82
Altman-Z 1.76
ROIC/WACC0.63
WACC7.16%
IVG.MI Yearly LT Debt VS Equity VS FCFIVG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

IVG has a Current Ratio of 1.98. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.98, IVG is in the better half of the industry, outperforming 76.70% of the companies in the same industry.
A Quick Ratio of 1.40 indicates that IVG should not have too much problems paying its short term obligations.
The Quick ratio of IVG (1.40) is better than 79.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.4
IVG.MI Yearly Current Assets VS Current LiabilitesIVG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

IVG shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.95%.
Measured over the past years, IVG shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.82% on average per year.
The Revenue has decreased by -6.97% in the past year.
The Revenue has been growing slightly by 5.06% on average over the past years.
EPS 1Y (TTM)-5.95%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-38.1%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-3.52%

3.2 Future

The Earnings Per Share is expected to grow by 10.81% on average over the next years. This is quite good.
Based on estimates for the next years, IVG will show a small growth in Revenue. The Revenue will grow by 3.81% on average per year.
EPS Next Y-9.88%
EPS Next 2Y7.16%
EPS Next 3Y9.76%
EPS Next 5Y10.81%
Revenue Next Year-2.33%
Revenue Next 2Y2.71%
Revenue Next 3Y3.58%
Revenue Next 5Y3.81%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IVG.MI Yearly Revenue VS EstimatesIVG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
IVG.MI Yearly EPS VS EstimatesIVG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.44 indicates a reasonable valuation of IVG.
Based on the Price/Earnings ratio, IVG is valued cheaper than 82.52% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.40. IVG is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 7.57, which indicates a rather cheap valuation of IVG.
Based on the Price/Forward Earnings ratio, IVG is valued cheaper than 89.32% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IVG to the average of the S&P500 Index (22.94), we can say IVG is valued rather cheaply.
Industry RankSector Rank
PE 11.44
Fwd PE 7.57
IVG.MI Price Earnings VS Forward Price EarningsIVG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IVG is valued a bit cheaper than the industry average as 79.61% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, IVG is valued a bit cheaper than 72.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.26
EV/EBITDA 5.46
IVG.MI Per share dataIVG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

IVG has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.35
EPS Next 2Y7.16%
EPS Next 3Y9.76%

3

5. Dividend

5.1 Amount

IVG has a Yearly Dividend Yield of 1.81%.
Compared to an average industry Dividend Yield of 2.44, IVG pays a bit more dividend than its industry peers.
IVG's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.81%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

27.33% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP27.33%
EPS Next 2Y7.16%
EPS Next 3Y9.76%
IVG.MI Yearly Income VS Free CF VS DividendIVG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M
IVG.MI Dividend Payout.IVG.MI Dividend Payout, showing the Payout Ratio.IVG.MI Dividend Payout.PayoutRetained Earnings

IVECO GROUP NV

BIT:IVG (10/17/2025, 7:00:00 PM)

18.075

-0.11 (-0.58%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-06 2025-11-06
Inst Owners39.4%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap4.90B
Analysts73.33
Price Target20.08 (11.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.81%
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.16%
EPS NY rev (1m)0.87%
EPS NY rev (3m)-6.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.06%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-2.34%
Valuation
Industry RankSector Rank
PE 11.44
Fwd PE 7.57
P/S 0.33
P/FCF 12.26
P/OCF 3.8
P/B 1.89
P/tB 8.88
EV/EBITDA 5.46
EPS(TTM)1.58
EY8.74%
EPS(NY)2.39
Fwd EY13.22%
FCF(TTM)1.47
FCFY8.16%
OCF(TTM)4.75
OCFY26.29%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.35
Profitability
Industry RankSector Rank
ROA 1.73%
ROE 12.39%
ROCE 6%
ROIC 4.53%
ROICexc 5.79%
ROICexgc 7.34%
OM 5%
PM (TTM) 2.17%
GM 16.49%
FCFM 2.7%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexcg growth 3Y26.65%
ROICexcg growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 14.82
Debt/EBITDA 2.37
Cap/Depr 119.97%
Cap/Sales 6%
Interest Coverage 250
Cash Conversion 86.98%
Profit Quality 124.22%
Current Ratio 1.98
Quick Ratio 1.4
Altman-Z 1.76
F-Score6
WACC7.16%
ROIC/WACC0.63
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.95%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-38.1%
EPS Next Y-9.88%
EPS Next 2Y7.16%
EPS Next 3Y9.76%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-3.52%
Revenue Next Year-2.33%
Revenue Next 2Y2.71%
Revenue Next 3Y3.58%
Revenue Next 5Y3.81%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year74.95%
EBIT Next 3Y29.26%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%